Glenmede Trust’s Parexel International Corp PRXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-9,437
| Closed | -$830K | – | 2913 |
|
|
2017
Q3 | $830K | Sell |
9,437
-4,572
| -33% | -$401K | ﹤0.01% | 800 |
|
|
2017
Q2 | $883K | Hold |
14,009
| – | – | ﹤0.01% | 786 |
|
|
2017
Q1 | $883K | Buy |
14,009
+69
| +0.5% | +$4.56K | ﹤0.01% | 786 |
|
|
2016
Q4 | $915K | Sell |
13,940
-30,120
| -68% | -$1.89M | 0.01% | 773 |
|
|
2016
Q3 | $3.06M | Sell |
44,060
-2,470
| -5% | -$167K | 0.02% | 544 |
|
|
2016
Q2 | $2.92M | Sell |
46,530
-8,781
| -16% | -$543K | 0.02% | 545 |
|
|
2016
Q1 | $3.47M | Sell |
55,311
-8,418
| -13% | -$519K | 0.02% | 500 |
|
|
2015
Q4 | $4.34M | Sell |
63,729
-14,834
| -19% | -$965K | 0.03% | 454 |
|
|
2015
Q3 | $4.86M | Buy |
78,563
+2,272
| +3% | +$153K | 0.04% | 405 |
|
|
2015
Q2 | $4.91M | Buy |
76,291
+9,972
| +15% | +$672K | 0.04% | 413 |
|
|
2015
Q1 | $4.57M | Buy |
66,319
+26,537
| +67% | +$1.69M | 0.03% | 441 |
|
|
2014
Q4 | $2.21M | Buy |
39,782
+17,352
| +77% | +$1M | 0.02% | 549 |
|
|
2014
Q3 | $1.41M | Buy |
22,430
+4,157
| +23% | +$237K | 0.01% | 613 |
|
|
2014
Q2 | $964K | Sell |
18,273
-829
| -4% | -$41.6K | 0.01% | 706 |
|
|
2014
Q1 | $1.03M | Sell |
19,102
-1,042
| -5% | -$53.4K | 0.01% | 681 |
|
|
2013
Q4 | $909K | Sell |
20,144
-3,928
| -16% | -$180K | 0.01% | 698 |
|
|
2013
Q3 | $1.21M | Buy |
24,072
+4,577
| +23% | +$224K | 0.01% | 621 |
|
|
2013
Q2 | $895K | Buy |
+19,495
| New | +$857K | 0.01% | 650 |
|
Other funds holding PRXL
Glenmede Trust's PRXL Position: Q4 2017 in Review
Glenmede Trust sold out of Parexel International Corp (PRXL) in Q4 2017, closing a stake of 9,437 shares — an estimated $830K sold.
Glenmede Trust first reported a position in PRXL in Q2 2013 and held it in 18 quarters. The position peaked at $4.91M in Q2 2015. 1 fund tracked by Wall St. Rank holds PRXL as of Q4 2017.
- Glenmede Trust reported no remaining Parexel International Corp position as of Q4 2017 after selling out during the quarter.
- Glenmede Trust sold 9,437 Parexel International Corp shares in Q4 2017, an estimated $830K.
- Glenmede Trust first reported a position in Parexel International Corp in Q2 2013 and held it in 18 quarters.
- Glenmede Trust's Parexel International Corp position peaked at $4.91M in Q2 2015.
- 1 fund tracked by Wall St. Rank held Parexel International Corp as of Q4 2017.
Based on Glenmede Trust's 13F filing for Q4 2017, filed 15 Feb 2018.